0000921895-20-003084.txt : 20201120 0000921895-20-003084.hdr.sgml : 20201120 20201120194610 ACCESSION NUMBER: 0000921895-20-003084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201118 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valentino Michael J CENTRAL INDEX KEY: 0001319551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36351 FILM NUMBER: 201333958 MAIL ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 4 1 form411577002val_11202020.xml OWNERSHIP DOCUMENT X0306 4 2020-11-18 0 0001497504 PLx Pharma Inc. PLXP 0001319551 Valentino Michael J 9 FISHERS LANE SUITE E SPARTA NJ 07871 1 1 0 0 Executive Chairman Common Stock 2020-11-18 4 P 0 264900 3.787 A 461690 D Stock Option (right to buy) 5.15 2020-11-18 4 A 0 160000 0 A 2030-11-18 Common Stock 160000 160000 D Warrants (right to buy) 4.31 2020-11-18 4 P 0 291390 A 2020-11-18 2025-11-18 Common Stock 291390 291390 D Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan. These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date. Issued pursuant to a private placement in connection with the purchase of immediately serparable units comprised of common stock and warrants. /s/ Natasha Giordano, as Attorney-in-Fact 2020-11-20